Neurology Department, AOR San Carlo, Potenza (IT), Italy; Neurology Department, Alto Vicentino Hospital, AULSS 7 Pedemontana, Santorso (IT), Italy; Neurology Department, Niguarda Ca Granda Hospital, Milan (IT), Italy.
Neurology Department, AOR San Carlo, Potenza (IT), Italy; Institute of Neurology Department of Medical and Surgical Sciences, Magna Græcia University, Catanzaro (IT), Italy.
J Neurol Sci. 2021 Jun 15;425:117467. doi: 10.1016/j.jns.2021.117467. Epub 2021 Apr 19.
The occurrence of cerebral venous thrombosis (CVT) in patients with spontaneous intracranial hypotension (SIH) raises difficult practical questions regarding the management of the two conditions. The first-line therapy for CVT is anticoagulation (AC); however, its potential benefit in SIH/CVT patients, especially if complicated by subdural haematoma, must be carefully evaluated taking account of the intracranial haemorrhage risk. Venous system recanalization and good prognosis in SIH/CVT patients treated with epidural blood patch (EBP), the main treatment option for SIH, have been already described.
We reviewed our cases of SIH complicated by CVT among a cohort of 445 SIH patients observed and treated during the last years. All published case reports and case series reporting patients with SIH and CVT were also ascertained and reviewed.
Eight (2%) out of 445 patients suffering with SIH, were also diagnosed with CVT. All patients observed had orthostatic headache, three of them experienced a change in their headache pattern over the SIH course. Six out of eight patients received both AC and EBP treatments. Two patients were treated using only AC or EBP. A bilateral subdural haematoma enlargement after 1 month of AC was observed in one case. Complete CVT recanalization after treatment was obtained in three patients, including two with multiple CVT at baseline; partial CVT recanalization was achieved in two patients. Three patients experienced no CVT recanalization. After 6-48 months' follow-up all patients were still asymptomatic.
The use of AC therapy should be weighed against the intracranial haemorrage risk and should be monitored carefully if initiated. Effective and prompt EBP, even without AC therapy, might lead to a good prognosis in selected cases.
自发性颅内低血压(SIH)患者发生脑静脉血栓形成(CVT)会引发关于两种疾病管理的棘手实际问题。CVT 的一线治疗是抗凝(AC);然而,必须仔细评估其在 SIH/CVT 患者中的潜在益处,尤其是如果伴有硬膜下血肿时,必须考虑颅内出血风险。已经描述了接受硬膜外血贴(EBP)治疗的 SIH/CVT 患者的静脉系统再通和良好预后,EBP 是 SIH 的主要治疗选择。
我们回顾了在过去几年观察和治疗的 445 例 SIH 患者队列中,由 SIH 并发 CVT 的病例。还确定并回顾了所有发表的报告 SIH 合并 CVT 的病例报告和病例系列。
445 例 SIH 患者中有 8 例(2%)也被诊断为 CVT。所有观察到的患者均有直立性头痛,其中 3 例在 SIH 过程中头痛模式发生改变。8 例患者中有 6 例接受了 AC 和 EBP 联合治疗。2 例患者仅接受 AC 或 EBP 治疗。1 例患者在接受 AC 治疗 1 个月后出现双侧硬膜下血肿增大。3 例患者治疗后完全再通 CVT,其中 2 例基线时存在多处 CVT;2 例患者部分再通 CVT。3 例患者 CVT 未再通。6-48 个月随访后,所有患者均无症状。
如果开始使用 AC 治疗,应权衡颅内出血风险,并仔细监测。有效的 EBP 治疗,即使没有 AC 治疗,也可能导致选定病例的良好预后。